vs
Side-by-side financial comparison of INTERGROUP CORP (INTG) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $17.3M, roughly 1.2× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -20.4%, a 29.2% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs 6.9%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-2.0M). Over the past eight quarters, INTERGROUP CORP's revenue compounded faster (7.8% CAGR vs 2.9%).
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
INTG vs SGHT — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $20.4M |
| Net Profit | $1.5M | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | 11.6% | -18.0% |
| Net Margin | 8.8% | -20.4% |
| Revenue YoY | 19.8% | 6.9% |
| Net Profit YoY | 155.6% | 64.9% |
| EPS (diluted) | $0.71 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3M | $20.4M | ||
| Q3 25 | $17.9M | $19.9M | ||
| Q2 25 | $16.2M | $19.6M | ||
| Q1 25 | $16.8M | $17.5M | ||
| Q4 24 | $14.4M | $19.1M | ||
| Q3 24 | $16.9M | $20.2M | ||
| Q2 24 | $13.4M | $21.4M | ||
| Q1 24 | $14.9M | $19.3M |
| Q4 25 | $1.5M | $-4.2M | ||
| Q3 25 | $-535.0K | $-8.2M | ||
| Q2 25 | $-2.2M | $-11.9M | ||
| Q1 25 | $-578.0K | $-14.2M | ||
| Q4 24 | $-2.7M | $-11.8M | ||
| Q3 24 | $-398.0K | $-11.1M | ||
| Q2 24 | $-4.9M | $-12.3M | ||
| Q1 24 | $-3.2M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 11.6% | -18.0% | ||
| Q3 25 | 15.3% | -39.7% | ||
| Q2 25 | 8.1% | -59.6% | ||
| Q1 25 | 14.0% | -79.2% | ||
| Q4 24 | 5.9% | -62.5% | ||
| Q3 24 | 18.5% | -55.7% | ||
| Q2 24 | 3.7% | -59.2% | ||
| Q1 24 | 4.8% | -76.4% |
| Q4 25 | 8.8% | -20.4% | ||
| Q3 25 | -3.0% | -41.0% | ||
| Q2 25 | -13.9% | -61.0% | ||
| Q1 25 | -3.4% | -80.8% | ||
| Q4 24 | -18.9% | -62.1% | ||
| Q3 24 | -2.4% | -54.9% | ||
| Q2 24 | -36.7% | -57.7% | ||
| Q1 24 | -21.3% | -84.4% |
| Q4 25 | $0.71 | $-0.07 | ||
| Q3 25 | $-0.25 | $-0.16 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | $-0.27 | $-0.28 | ||
| Q4 24 | $-1.26 | $-0.23 | ||
| Q3 24 | $-0.18 | $-0.22 | ||
| Q2 24 | — | $-0.25 | ||
| Q1 24 | $-1.44 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.5M | $92.0M |
| Total DebtLower is stronger | $233.2M | $42.4M |
| Stockholders' EquityBook value | $-85.2M | $63.9M |
| Total Assets | $101.1M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.5M | $92.0M | ||
| Q3 25 | $6.0M | $92.4M | ||
| Q2 25 | $6.1M | $101.5M | ||
| Q1 25 | $4.8M | $108.8M | ||
| Q4 24 | $15.4M | $120.4M | ||
| Q3 24 | $12.2M | $118.6M | ||
| Q2 24 | $11.6M | $118.2M | ||
| Q1 24 | $19.5M | $127.3M |
| Q4 25 | $233.2M | $42.4M | ||
| Q3 25 | $237.8M | $42.4M | ||
| Q2 25 | $240.5M | $42.4M | ||
| Q1 25 | $241.5M | $42.4M | ||
| Q4 24 | $227.2M | $40.0M | ||
| Q3 24 | $218.1M | $37.1M | ||
| Q2 24 | $225.7M | $35.0M | ||
| Q1 24 | $225.0M | $35.0M |
| Q4 25 | $-85.2M | $63.9M | ||
| Q3 25 | $-86.7M | $64.3M | ||
| Q2 25 | $-86.1M | $70.0M | ||
| Q1 25 | $-84.5M | $77.6M | ||
| Q4 24 | $-83.9M | $87.5M | ||
| Q3 24 | $-80.9M | $95.0M | ||
| Q2 24 | $-80.3M | $101.6M | ||
| Q1 24 | $-76.4M | $109.2M |
| Q4 25 | $101.1M | $115.3M | ||
| Q3 25 | $102.5M | $116.3M | ||
| Q2 25 | $104.1M | $122.0M | ||
| Q1 25 | $103.2M | $129.7M | ||
| Q4 24 | $110.6M | $142.8M | ||
| Q3 24 | $109.3M | $143.6M | ||
| Q2 24 | $107.8M | $149.7M | ||
| Q1 24 | $119.0M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-23.0K | $-1.8M |
| Free Cash FlowOCF − Capex | $-481.0K | $-2.0M |
| FCF MarginFCF / Revenue | -2.8% | -9.7% |
| Capex IntensityCapex / Revenue | 2.6% | 0.8% |
| Cash ConversionOCF / Net Profit | -0.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | $739.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-23.0K | $-1.8M | ||
| Q3 25 | $-296.0K | $-8.7M | ||
| Q2 25 | $5.9M | $-7.5M | ||
| Q1 25 | $-854.0K | $-11.6M | ||
| Q4 24 | $-781.0K | $-3.5M | ||
| Q3 24 | $3.4M | $362.0K | ||
| Q2 24 | $6.8M | $-9.5M | ||
| Q1 24 | $1.9M | $-9.8M |
| Q4 25 | $-481.0K | $-2.0M | ||
| Q3 25 | $-1.3M | $-8.9M | ||
| Q2 25 | $3.6M | $-7.8M | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.1M | $-3.6M | ||
| Q3 24 | $3.1M | $311.0K | ||
| Q2 24 | $2.7M | $-9.5M | ||
| Q1 24 | $1.1M | $-9.9M |
| Q4 25 | -2.8% | -9.7% | ||
| Q3 25 | -7.1% | -44.7% | ||
| Q2 25 | 22.5% | -39.6% | ||
| Q1 25 | -6.8% | — | ||
| Q4 24 | -7.8% | -18.9% | ||
| Q3 24 | 18.3% | 1.5% | ||
| Q2 24 | 20.4% | -44.7% | ||
| Q1 24 | 7.6% | -51.4% |
| Q4 25 | 2.6% | 0.8% | ||
| Q3 25 | 5.4% | 0.9% | ||
| Q2 25 | 13.9% | 1.1% | ||
| Q1 25 | 1.8% | 0.0% | ||
| Q4 24 | 2.4% | 0.7% | ||
| Q3 24 | 1.6% | 0.3% | ||
| Q2 24 | 30.4% | 0.4% | ||
| Q1 24 | 4.9% | 0.6% |
| Q4 25 | -0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
